These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 943692)

  • 21. Characterization and tissue localization of catecholamine synthesizing enzymes.
    Goldstein M; Fuxe K; Hökfelt T
    Pharmacol Rev; 1972 Jun; 24(2):293-309. PubMed ID: 4564603
    [No Abstract]   [Full Text] [Related]  

  • 22. Purification of tyrosine hydroxylase from pheochromocytoma tumors.
    Park DH; Goldstein M
    Life Sci; 1976 Jan; 18(1):55-60. PubMed ID: 2828
    [No Abstract]   [Full Text] [Related]  

  • 23. Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.
    Markey KA; Kondo H; Shenkman L; Goldstein M
    Mol Pharmacol; 1980 Jan; 17(1):79-85. PubMed ID: 6104286
    [No Abstract]   [Full Text] [Related]  

  • 24. Developmental pattern of dopamine beta-hydroxylase induction in the adrenals of the rat. Influence of neonatal hypothyroidism.
    Chami N; Gripois D
    J Dev Physiol; 1988 Oct; 10(5):445-9. PubMed ID: 3221059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine-beta-hydroxylase activity in plasma, spleen and adrenal gland of streptozotocin-diabetic rats: correlation with cataracts.
    Muñoz JA; García-Estañ J; Canteras M; Quesada T; Miras-Portugal MT
    Rev Esp Fisiol; 1986 Mar; 42(1):63-70. PubMed ID: 3520719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase.
    Palatini P
    Biochem Int; 1985 Oct; 11(4):565-72. PubMed ID: 4084318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of dopamine-beta-hydroxylase by hydralazine.
    Liu TZ; Shen JT; Loken HF
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):294-7. PubMed ID: 4812865
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of acupuncture analgesia on dopamine-beta-hydroxylase activity in different brain areas and adrenal glands of the guinea pig].
    Chen J; Wang XH; Yang JX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Jun; 3 Suppl 1():69-71. PubMed ID: 6459884
    [No Abstract]   [Full Text] [Related]  

  • 29. [Proceedings: Serum dopamine beta hydroxylase activity in various diseases].
    Hara I; Itatsu T; Kojima T; Suzuki S; Mizuno M
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):641. PubMed ID: 4476634
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of dopamine beta-monooxygenase by histidine.
    Izumi H; Hayakari M; Kondo Y; Takemoto T
    Hoppe Seylers Z Physiol Chem; 1975 Nov; 356(11):1831-3. PubMed ID: 1205455
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies raised against different oligopeptide segments of human dopamine-beta-hydroxylase.
    Nagatsu I; Kobayashi K; Fujii T; Komori K; Sekiguchi K; Titani K; Fujita K; Nagatsu T
    Neurosci Lett; 1990 Dec; 120(2):141-5. PubMed ID: 2293101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in the relative rate of synthesis of dopamine-beta-hydroxylase in the nucleus locus coeruleus elicited by reserpine.
    Ross RA; Joh TH; Reis DJ
    J Neurochem; 1978 Dec; 31(6):1491-500. PubMed ID: 551128
    [No Abstract]   [Full Text] [Related]  

  • 33. The application of immunological techniques to the study of enzymes regulating catecholamine synthesis and degradation.
    Hartman BK; Udenfriend S
    Pharmacol Rev; 1972 Jun; 24(2):311-30. PubMed ID: 4564604
    [No Abstract]   [Full Text] [Related]  

  • 34. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
    Wocial B; Januszewicz W; Siedlecki I; Feltynowski T; Debiński W
    Endokrinologie; 1982 Feb; 79(1):131-9. PubMed ID: 7084126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of dopamine-beta-hydroxylase in vitro in rat heart & adrenal tissue.
    Srivastava M; Kapoor NK
    Indian J Exp Biol; 1980 Jun; 18(6):647-9. PubMed ID: 6254872
    [No Abstract]   [Full Text] [Related]  

  • 36. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanism of secretion from the adrenal medulla. VII. Effect of insulin administration on the buoyant density, dopamine -hydroxylase, and catecholamine content of adrenal storage vesicles.
    Viveros OH; Arqueros L; Kirshner N
    Mol Pharmacol; 1971 Jul; 7(4):444-54. PubMed ID: 5113237
    [No Abstract]   [Full Text] [Related]  

  • 38. Proportionally between dopamine-beta-hydroxylase activity and immunoreactive protein concentration in human serum.
    Wooten GF; Ciaranello RD
    Pharmacology; 1974; 12(4-5):272-82. PubMed ID: 4449890
    [No Abstract]   [Full Text] [Related]  

  • 39. Deduction of kinetic mechanism in multisubstrate enzyme reactions from tritium isotope effects. Application to dopamine beta-hydroxylase.
    Klinman JP; Humphries H; Voet JG
    J Biol Chem; 1980 Dec; 255(24):11648-51. PubMed ID: 7002926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum dopamine beta hydrolase and hypertension].
    Lamprecht F
    Dtsch Med Wochenschr; 1977 Aug; 102(31):1128-32. PubMed ID: 330131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.